Sapan Gai, CCO at Sovereign Metals, discusses their superior graphite test results. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSLA.L Regulatory News (SLA)

  • There is currently no data for SLA

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - UDG Healthcare PLC

16 Jun 2021 10:20

RNS Number : 0869C
Standard Life Aberdeen plc
16 June 2021
 

Ap19

 

 

FORM 8.3

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

 

1. KEY INFORMATION

 

Name of person dealing (Note 1)

Standard Life Aberdeen plc

Company dealt in

UDG Healthcare plc

Class of relevant security to which the dealings being disclosed relate (Note 2)

€0.05 ordinary shares

Date of dealing

15 June 2021

 

2. INTERESTS AND SHORT POSITIONS

 

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

 

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

3,771,167 (1.50%)

 

(2) Derivatives (other than options)

 

 

(3) Options and agreements to purchase/sell

 

 

Total

 

3,771,167 (1.50%)

 

       

 

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

 

 

 

(2) Derivatives (other than options)

 

 

 

(3) Options and agreements to purchase/sell

 

 

Total

 

 

       

 

Ap20

 

 

1. DEALINGS (Note 4)

 

(a) Purchases and sales

 

 

Purchase/sale

 

Number of relevant securities

 

Price per unit (Note 5)

Purchase

381

GBP 10.440

 

 

(b) Derivatives transactions (other than options transactions)

 

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit

(Note 5)

 

 

 

 

 

 

(c) Options transactions in respect of existing relevant securities

 

 

(i) Writing, selling, purchasing or varying

 

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

 

 

 

 

 

 

 

 

 

(ii) Exercising

 

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

 

 

 

 

(d) Other dealings (including transactions in respect of new securities) (Note 4)

 

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

 

Ap21

 

2. OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

 

 

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the 

voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition 

or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

 

 

 

 

 

 

 

 

 

 

Is a Supplemental Form 8 attached? (Note 9)  NO

 

Date of disclosure

16 June 2021

Contact name

Sophie Perkins

Telephone number

+44 (0) 131 372 1043

If a connected EFM, name of offeree/offeror with which connected

 

If a connected EFM, state nature of connection (Note 10)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ISEFFMLTMTBBMRB
Date   Source Headline
4th Mar 202111:58 amRNSForm 8.3 - Aggreko PLC
4th Mar 202111:57 amRNSForm 8.3 - RSA Insurance Group plc
3rd Mar 20213:52 pmRNSHolding(s) in Company
3rd Mar 202111:07 amRNSForm 8.3 - RSA Insurance Group plc
3rd Mar 20219:24 amRNSHolding(s) in Company
1st Mar 202111:18 amRNSTotal Voting Rights
1st Mar 202111:18 amRNSForm 8.3 - William Hill plc
1st Mar 202111:17 amRNSForm 8.3 - RSA Insurance Group plc
26th Feb 20215:21 pmRNSHolding(s) in Company
26th Feb 20211:31 pmRNSForm 8.3 - RSA Insurance Group plc
25th Feb 202111:48 amRNSForm 8.3 - G4S plc
25th Feb 202111:34 amRNSForm 8.3 - William Hill plc
25th Feb 202111:26 amRNSForm 8.3 - Aggreko plc
25th Feb 202111:24 amRNSForm 8.3 - RSA Insurance Group plc
23rd Feb 20217:00 amRNSUpdate on Strategic Partnership with PGH
22nd Feb 20215:26 pmRNSHolding(s) in Company
22nd Feb 202111:31 amRNSForm 8.3 - William Hill plc
22nd Feb 202111:08 amRNSForm 8.3 - RSA Insurance Group plc
19th Feb 202111:05 amRNSForm 8.3 - William Hill plc
19th Feb 202111:03 amRNSForm 8.3 - Aggreko plc
18th Feb 20214:26 pmRNSHolding(s) in Company
18th Feb 202111:06 amRNSForm 8.3 - G4S plc
18th Feb 202110:54 amRNSForm 8.3 - William Hill plc
18th Feb 202110:50 amRNSForm 8.3 - Aggreko plc
18th Feb 202110:45 amRNSForm 8.3 - RSA Insurance Group plc
17th Feb 202112:31 pmRNSForm 8.3 - Future plc
17th Feb 202112:23 pmRNSForm 8.3 - William Hill plc
17th Feb 202112:07 pmRNSForm 8.3 - RSA Insurance Group plc
17th Feb 20218:05 amRNSHolding(s) in Company
16th Feb 202112:26 pmRNSForm 8.3 - Future plc
15th Feb 202110:53 amRNSForm 8.3 - Future plc
12th Feb 20214:25 pmRNSHolding(s) in Company
12th Feb 20214:12 pmRNSHolding(s) in Company
12th Feb 20211:00 pmRNSHolding(s) in Company
12th Feb 202112:36 pmRNSForm 8.3 - Future plc
12th Feb 202112:36 pmRNSForm 8.3 - G4S plc
12th Feb 202112:33 pmRNSForm 8.3 - Aggreko plc
12th Feb 202112:33 pmRNSForm 8.3 - William Hill plc
12th Feb 202112:29 pmRNSForm 8.3 - RSA Insurance Group plc
11th Feb 202110:26 amRNSForm 8.3 - Future plc
11th Feb 202110:15 amRNSDirector Declaration
11th Feb 20217:00 amRNSTransaction in Own Shares
10th Feb 20214:50 pmRNSHolding(s) in Company
10th Feb 20213:10 pmRNSHolding(s) in Company
10th Feb 20213:08 pmRNSHolding(s) in Company
10th Feb 202110:19 amRNSForm 8.3 - Future plc
10th Feb 20217:16 amRNSNotification of Major Holding(s)
10th Feb 20217:00 amRNSTransaction in Own Shares
9th Feb 202111:27 amRNSForm 8.3 - G4S plc
9th Feb 202111:25 amRNSForm 8.3 - William Hill plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.